Serving the entire Gulf Coast area, Nielsen & Treas, LLC, is a law firm based in Metairie, Louisiana. Dedicated to giving back, the lawyers at Nielsen & Treas, LLC, support the efforts of St. Jude Children’s Research Hospital and its fight to end childhood cancers.In December 2018, St. Jude announced it had received a $50 million donation from AbbVie - a renowned biopharmaceutical firm - that will help finance a new Family Commons area at the hospital’s Memphis location. The donation is the largest in St. Jude’s history. According to St. Jude, the Family Commons will be a floor completely devoted to relaxation and recovery. No medical treatments will take place in the commons; its entire focus will be on a relaxing environment for families of children battling cancer. In addition to walking areas and gardens, the Family Commons will have play areas for children. More information about St. Jude and its work is available at www.stjude.org.
Located in Metairie, Louisiana, Nielsen & Treas, LLC, offers legal services to insurance companies. Supportive of charitable causes, members of Nielsen & Treas, LLC, donate to St. Jude Children’s Research Hospital. St. Jude helps improve treatment outcomes for children with some of the most difficult forms of cancer, such as leukemia and lymphoma. The hospital accepts referrals from doctors of patients who have complex forms of these diseases and then coordinates care among different experts, including pediatric oncologists and radiation specialists. Patients arriving at St. Jude first undergo a diagnostic study, after which a treatment protocol is prescribed. This protocol is then explained to patients' parents in detail. Travel and accommodation information is also given since most patients are required to stay in Memphis during the early stages of their therapy. St. Jude matches patients with appropriate clinical research programs to optimize the probability of successful treatment. The patients’ parents and their referring physicians are given regular updates on the progress of therapies. Afterward, monitoring and follow-up examinations are performed to address residual effects and collect epidemiological data that will help improve future therapies.
